Sorrento Therapeutics, created in 2000 (United States), from 2214 competing brands. The Sorrento Therapeutics brand is owned by Sorrento Therapeutics Inc, a company listed in Francfort. Sorrento Therapeutics belongs to the Biotechnology business sector.